• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Impact of SARS-CoV-2 infection on tuberculosis outcome and follow-up in Italy during the first COVID-19 pandemic wave: a nationwide online survey.在意大利第一波新冠疫情期间，严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染对结核病结局及随访的影响：一项全国性在线调查
Infez Med. 2022 Sep 1;30(3):418-426. doi: 10.53854/liim-3003-10. eCollection 2022.
2
Coinfection of tuberculosis and COVID-19 limits the ability to in vitro respond to SARS-CoV-2.结核分枝杆菌和 COVID-19 的双重感染限制了体外对 SARS-CoV-2 的反应能力。
Int J Infect Dis. 2021 Dec;113 Suppl 1:S82-S87. doi: 10.1016/j.ijid.2021.02.090. Epub 2021 Mar 10.
3
COVID-19 and tuberculosis: A mathematical model based forecasting in Delhi, India.新型冠状病毒肺炎与结核病：基于数学模型对印度德里的预测
Indian J Tuberc. 2020 Apr;67(2):177-181. doi: 10.1016/j.ijtb.2020.05.006. Epub 2020 May 12.
4
The paradigm shift in the approach to management of latent tuberculosis infection in high tuberculosis burden countries.高结核病负担国家对潜伏性结核感染管理方法的范式转变。
Expert Rev Respir Med. 2021 Jul;15(7):899-910. doi: 10.1080/17476348.2021.1862652. Epub 2021 Feb 14.
5
TB and COVID-19: An Exploration of the Characteristics and Resulting Complications of Co-infection.结核病和 COVID-19：合并感染的特征和相关并发症探讨。
Front Biosci (Schol Ed). 2022 Mar 1;14(1):6. doi: 10.31083/j.fbs1401006.
6
Characterization of epidemiological distribution and outcome of COVID-19 in patients with hereditary hemorrhagic telangiectasia: a nationwide retrospective multi-centre study during first wave in Italy.遗传性出血性毛细血管扩张症患者 COVID-19 的流行病学分布和结局特征：意大利第一波疫情期间的全国性回顾性多中心研究。
Orphanet J Rare Dis. 2021 Sep 8;16(1):378. doi: 10.1186/s13023-021-02000-2.
7
[Friend or Foe? Evaluation of BCG Vaccine and Latent Tuberculosis Infection Effect in Patients Diagnosed with COVID-19 Infection].[敌友难辨？卡介苗疫苗及潜伏性结核感染对新冠病毒感染确诊患者的影响评估]
Mikrobiyol Bul. 2021 Jul;55(3):300-310. doi: 10.5578/mb.20219802.
8
Impact of the COVID-19 pandemic on contact tracing of patients with pulmonary tuberculosis.COVID-19 大流行对肺结核患者接触者追踪的影响。
Eur J Public Health. 2022 Aug 1;32(4):643-647. doi: 10.1093/eurpub/ckac031.
9
Screening for Latent Tuberculosis Infection in People Living with HIV: TUBHIVIT Project, a Multicenter Italian Study.HIV 感染者潜伏性结核病感染筛查：TUBHIVIT 项目，一项多中心意大利研究。
Viruses. 2024 May 14;16(5):777. doi: 10.3390/v16050777.
10
Authors' response: Occupation and SARS-CoV-2 infection risk among workers during the first pandemic wave in Germany: potential for bias.作者回复：在德国首次大流行期间，工人的职业与 SARS-CoV-2 感染风险：潜在的偏见。
Scand J Work Environ Health. 2022 Sep 1;48(7):588-590. doi: 10.5271/sjweh.4061. Epub 2022 Sep 25.

引用本文的文献

1
Impact of the COVID-19 pandemic on tuberculosis services in a rural area of Senegal.新冠疫情对塞内加尔农村地区结核病服务的影响。
Infez Med. 2025 Sep 1;33(3):321-328. doi: 10.53854/liim-3303-9. eCollection 2025.
2
Tuberculosis morbidity and mortality during the COVID-19 pandemic: a life-threatening complex challenge.2019冠状病毒病大流行期间的结核病发病率和死亡率：一项危及生命的复杂挑战。
Front Cell Infect Microbiol. 2024 Oct 1;14:1423081. doi: 10.3389/fcimb.2024.1423081. eCollection 2024.
3
How We Treat Drug-Susceptible Pulmonary Tuberculosis: A Practical Guide for Clinicians.我们如何治疗药物敏感型肺结核：临床医生实用指南
Antibiotics (Basel). 2023 Dec 14;12(12):1733. doi: 10.3390/antibiotics12121733.
4
Latent TB Infection, Vitamin D Status and COVID-19 Severity in Mongolian Patients.蒙古患者潜伏性结核感染、维生素 D 状况与 COVID-19 严重程度的关系
Nutrients. 2023 Sep 14;15(18):3979. doi: 10.3390/nu15183979.
5
Cohort study of the mortality among patients in New York City with tuberculosis and COVID-19, March 2020 to June 2022.2020年3月至2022年6月纽约市肺结核合并新冠肺炎患者死亡率的队列研究
PLOS Glob Public Health. 2023 Apr 26;3(4):e0001758. doi: 10.1371/journal.pgph.0001758. eCollection 2023.
6
COVID-19 and tuberculosis coinfection: outcomes depend on severity of COVID-19 and comorbid conditions.新型冠状病毒肺炎与结核病合并感染：结局取决于新型冠状病毒肺炎的严重程度和合并症。
Infez Med. 2023 Mar 1;31(1):127-129. doi: 10.53854/liim-3101-18. eCollection 2022.
7
Clinical impact of COVID-19 on tuberculosis.新型冠状病毒肺炎对结核病的临床影响。
Infez Med. 2022 Dec 1;30(4):495-500. doi: 10.53854/liim-3004-3. eCollection 2022.

本文引用的文献

1
Estimating the Effects of the COVID-19 Outbreak on the Reductions in Tuberculosis Cases and the Epidemiological Trends in China: A Causal Impact Analysis.评估新冠疫情对中国结核病病例减少及流行趋势的影响：因果影响分析
Infect Drug Resist. 2021 Nov 6;14:4641-4655. doi: 10.2147/IDR.S337473. eCollection 2021.
2
Gauging the impact of the COVID-19 pandemic on tuberculosis services: a global study.评估 COVID-19 大流行对结核病服务的影响：一项全球研究。
Eur Respir J. 2021 Nov 11;58(5). doi: 10.1183/13993003.01786-2021. Print 2021 Nov.
3
The impact of COVID-19 on TB: a review of the data.COVID-19 对结核病的影响：数据回顾。
Int J Tuberc Lung Dis. 2021 Jun 1;25(6):436-446. doi: 10.5588/ijtld.21.0148.
4
Relationship of SARS-CoV-2-specific CD4 response to COVID-19 severity and impact of HIV-1 and tuberculosis coinfection.SARS-CoV-2 特异性 CD4 反应与 COVID-19 严重程度的关系以及 HIV-1 和结核分枝杆菌合并感染的影响。
J Clin Invest. 2021 Jun 15;131(12). doi: 10.1172/JCI149125.
5
Impact of the COVID-19 pandemic on tuberculosis management in Spain.COVID-19 大流行对西班牙结核病管理的影响。
Int J Infect Dis. 2021 Jul;108:300-305. doi: 10.1016/j.ijid.2021.04.075. Epub 2021 Apr 27.
6
Coinfection of tuberculosis and COVID-19 limits the ability to in vitro respond to SARS-CoV-2.结核分枝杆菌和 COVID-19 的双重感染限制了体外对 SARS-CoV-2 的反应能力。
Int J Infect Dis. 2021 Dec;113 Suppl 1:S82-S87. doi: 10.1016/j.ijid.2021.02.090. Epub 2021 Mar 10.
7
The Impact of the SARS-CoV-2 Outbreak on the Psychological Flexibility and Behaviour of Cancelling Medical Appointments of Italian Patients with Pre-Existing Medical Condition: The "ImpACT-COVID-19 for Patients" Multi-Centre Observational Study.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）疫情对意大利患有基础疾病患者心理灵活性及取消医疗预约行为的影响：“患者的ImpACT-COVID-19”多中心观察性研究
Int J Environ Res Public Health. 2021 Jan 5;18(1):340. doi: 10.3390/ijerph18010340.
8
Concurrent cavitary pulmonary tuberculosis and COVID-19 pneumonia with in vitro immune cell anergy.并发空洞性肺结核与 COVID-19 肺炎伴体外免疫细胞无反应性。
Infection. 2021 Oct;49(5):1061-1064. doi: 10.1007/s15010-021-01576-y. Epub 2021 Jan 17.
9
Non-COVID-19 admissions to the emergency department during the pandemic second wave in Italy: What is changed from the first wave?意大利疫情第二波期间急诊科非新冠病毒疾病的收治情况：与第一波相比有哪些变化？
Am J Emerg Med. 2021 Jul;45:625-626. doi: 10.1016/j.ajem.2020.11.046. Epub 2020 Nov 26.
10
Worldwide Effects of Coronavirus Disease Pandemic on Tuberculosis Services, January-April 2020.2020 年 1 月至 4 月，冠状病毒病大流行对结核病服务的全球影响。
Emerg Infect Dis. 2020 Nov;26(11):2709-2712. doi: 10.3201/eid2611.203163. Epub 2020 Sep 11.

在意大利第一波新冠疫情期间，严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染对结核病结局及随访的影响：一项全国性在线调查

Impact of SARS-CoV-2 infection on tuberculosis outcome and follow-up in Italy during the first COVID-19 pandemic wave: a nationwide online survey.

作者信息

Canetti Diana, Antonello Roberta Maria, Saderi Laura, Giro Mara, Goletti Delia, Sarmati Loredana, Rodari Paola, Bocchino Marialuisa, Schirò Miriam, Riccardi Niccolò, Sotgiu Giovanni

机构信息

StopTB Italia Onlus, Milan, Italy.

Department of Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.

出版信息

Infez Med. 2022 Sep 1;30(3):418-426. doi: 10.53854/liim-3003-10. eCollection 2022.

DOI:10.53854/liim-3003-10
PMID:36148161
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9448321/
Abstract

BACKGROUND

SARS-CoV-2 pandemic affected tuberculosis (TB) management. This Italian nationwide survey assessed COVID-19 impact on TB care and outcomes.

MATERIALS AND METHODS

Twenty-one hospitals or referral centres fulfilled an online survey. Primary objective was to describe clinical features, outcomes and retention in care in subjects with latent TB infection (LTBI) or disease over the first wave of COVID-19 pandemic. Secondary objectives were the assessment of risk factors, co-morbidities, diagnostics, radiological findings, and outcomes of COVID-19 in the study population.

RESULTS

254 patients with LTBI or active TB were included. In co-infected (SARS-CoV-2, LTBI/TB) patients, recovery occurred in 29/32 (90.6%) cases, death in one case. High retention in care was preserved.

CONCLUSION

in our cohort, outcomes did not seem to be adversely conditioned by incident COVID-19.

摘要

背景

严重急性呼吸综合征冠状病毒2（SARS-CoV-2）大流行影响了结核病（TB）的管理。这项意大利全国性调查评估了2019冠状病毒病（COVID-19）对结核病治疗及治疗结果的影响。

材料与方法

21家医院或转诊中心完成了一项在线调查。主要目的是描述在COVID-19大流行第一波期间，潜伏性结核感染（LTBI）或结核病患者的临床特征、治疗结果及治疗依从性。次要目的是评估研究人群中COVID-19的危险因素、合并症、诊断、影像学检查结果及治疗结果。

结果

纳入254例LTBI或活动性结核病患者。在合并感染（SARS-CoV-2、LTBI/TB）的患者中，29/32例（90.6%）康复，1例死亡。治疗依从性保持较高水平。

结论

在我们的队列中，COVID-19的发生似乎并未对治疗结果产生不利影响。